Company intelligence / Profile preview

Ortho Women's Health & Urology

Raritan, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Ortho Women's Health & Urology was a specialized business unit of Ortho-McNeil-Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. The division focused on developing and marketing therapeutic solutions for reproductive health, menopause management, and urological conditions. It was widely recognized for its market-leading portfolio of oral contraceptives and hormonal therapies. Following a corporate restructuring in 2011, its operations and product lines were integrated into Janssen Pharmaceuticals.

Therapeutic areas: UrologyWomen's HealthInfectious Diseases
Modalities: Small moleculeHormone
Industry: Pharma

Beyond the preview

Go deeper on Ortho Women's Health & Urology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ortho Women's Health & Urology.

Explore the full profile